Acute Cholecystitis
Authors:
- Carsten N. GuttCGCarsten N. Gutt
- Jens EnckeJEJens Encke
- Jörg KöningerJKJörg Köninger
- Julian-Camill HarnossJHJulian-Camill Harnoss
- Kilian WeigandKWKilian Weigand
- Karl KipfmüllerKKKarl Kipfmüller
- Oliver SchunterOSOliver Schunter
- Thorsten GötzeTGThorsten Götze
- Markus T. GollingMGMarkus T. Golling
- Markus MengesMMMarkus Menges
- Ernst KlarEKErnst Klar
- Katharina FeilhauerKFKatharina Feilhauer
Top Cited Papers
- 1 September 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 258 (3) , 385-393
Abstract
Acute cholecystitis is a common disease, and laparoscopic surgery is the standard of care. Optimal timing of surgery for acute cholecystitis remains controversial: either early surgery shortly after hospital admission or delayed elective surgery after a conservative treatment with antibiotics. The ACDC ("Acute Cholecystitis-early laparoscopic surgery versus antibiotic therapy and Delayed elective Cholecystectomy") study is a randomized, prospective, open-label, parallel group trial. Patients were randomly assigned to receive immediate surgery within 24 hours of hospital admission (group ILC) or initial antibiotic treatment, followed by delayed laparoscopic cholecystectomy at days 7 to 45 (group DLC). For infection, all patients were treated with moxifloxacin for at least 48 hours. Primary endpoint was occurrence of predefined relevant morbidity within 75 days. Secondary endpoints were as follows: (1) 75-day morbidity using a scoring system; (2) conversion rate; (3) change of antibiotic therapy; (4) mortality; (5) costs; and (6) length of hospital stay. Morbidity rate was significantly lower in group ILC (304 patients) than in group DLC (314 patients): 11.8% versus 34.4%. Conversion rate to open surgery and mortality did not differ significantly between groups. Mean length of hospital stay (5.4 days vs 10.0 days; P < 0.001) and total hospital costs (€2919 vs €4262; P < 0.001) were significantly lower in group ILC. In this large, randomized trial, laparoscopic cholecystectomy within 24 hours of hospital admission was shown to be superior to the conservative approach concerning morbidity and costs. Therefore, we believe that immediate laparoscopic cholecystectomy should become therapy of choice for acute cholecystitis in operable patients. (NCT00447304).Keywords
This publication has 24 references indexed in Scilit:
- Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitisBritish Journal of Surgery, 2010
- Prospective randomized trial using cost–utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder diseaseBritish Journal of Surgery, 2009
- Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis of randomized clinical trialsThe American Journal of Surgery, 2008
- Clinical update: early surgery for acute cholecystitisThe Lancet, 2007
- Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitisSurgical Endoscopy, 2005
- Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective randomized trialSurgical Endoscopy, 2004
- Timing of Cholecystectomy for Acute Calculous Cholecystitis: A Meta-AnalysisAmerican Journal of Gastroenterology, 2004
- Management of acute cholecystitis in the laparoscopic era: Results of a prospective, randomized clinical trialJournal of Gastrointestinal Surgery, 2003
- Prospective Evaluation of Emergency Versus Delayed Laparoscopic Cholecystectomy for Early CholecystitisSurgical Laparoscopy, Endoscopy & Percutaneous Techniques, 2003
- Elective laparoscopic cholecystectomy for "all-comers"The Lancet, 1991